213 related articles for article (PubMed ID: 36029394)
21. Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways.
de Cubas AA; Leandro-García LJ; Schiavi F; Mancikova V; Comino-Méndez I; Inglada-Pérez L; Perez-Martinez M; Ibarz N; Ximénez-Embún P; López-Jiménez E; Maliszewska A; Letón R; Gómez Graña A; Bernal C; Alvarez-Escolá C; Rodríguez-Antona C; Opocher G; Muñoz J; Megias D; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):477-93. PubMed ID: 23660872
[TBL] [Abstract][Full Text] [Related]
22. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors.
Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y
Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801
[TBL] [Abstract][Full Text] [Related]
23. Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.
Oudijk L; van Nederveen F; Badoual C; Tissier F; Tischler AS; Smid M; Gaal J; Lepoutre-Lussey C; Gimenez-Roqueplo AP; Dinjens WN; Korpershoek E; de Krijger R; Favier J
PLoS One; 2015; 10(3):e0121361. PubMed ID: 25794004
[TBL] [Abstract][Full Text] [Related]
24. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
Fishbein L; Nathanson KL
Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592
[TBL] [Abstract][Full Text] [Related]
25. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients.
Warren M; Matsuno R; Tran H; Shimada H
Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989
[TBL] [Abstract][Full Text] [Related]
26. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.
Fishbein L
Hematol Oncol Clin North Am; 2016 Feb; 30(1):135-50. PubMed ID: 26614373
[TBL] [Abstract][Full Text] [Related]
27. Paraganglioma of the Head and Neck: A Review.
Sandow L; Thawani R; Kim MS; Heinrich MC
Endocr Pract; 2023 Feb; 29(2):141-147. PubMed ID: 36252779
[TBL] [Abstract][Full Text] [Related]
28. Cancer Stem Cells in Pheochromocytoma and Paraganglioma.
Scriba LD; Bornstein SR; Santambrogio A; Mueller G; Huebner A; Hauer J; Schedl A; Wielockx B; Eisenhofer G; Andoniadou CL; Steenblock C
Front Endocrinol (Lausanne); 2020; 11():79. PubMed ID: 32158431
[TBL] [Abstract][Full Text] [Related]
29. Chromogranin A in a Cohort of Pheochromocytomas and Paragangliomas: Usefulness at Diagnosis and as an Early Biomarker of Recurrence.
Parisien-La Salle S; Provençal M; Bourdeau I
Endocr Pract; 2021 Apr; 27(4):318-325. PubMed ID: 33581325
[TBL] [Abstract][Full Text] [Related]
30. Pheochromocytomas and Hypertension.
Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
[TBL] [Abstract][Full Text] [Related]
31. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
[TBL] [Abstract][Full Text] [Related]
32. Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma.
Liu P; Li M; Guan X; Yu A; Xiao Q; Wang C; Hu Y; Zhu F; Yin H; Yi X; Liu L
J Kidney Cancer VHL; 2018; 5(4):14-22. PubMed ID: 30613466
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis of pheochromocytomas and paragangliomas.
McNichol AM
Endocr Pathol; 2001; 12(4):407-15. PubMed ID: 11914474
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations.
Oudijk L; Neuhofer CM; Lichtenauer UD; Papathomas TG; Korpershoek E; Stoop H; Oosterhuis JW; Smid M; Restuccia DF; Robledo M; de Cubas AA; Mannelli M; Gimenez-Roqueplo AP; Dinjens WN; Beuschlein F; de Krijger RR
Eur J Endocrinol; 2015 Jul; 173(1):43-52. PubMed ID: 25916394
[TBL] [Abstract][Full Text] [Related]
35. A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy.
Pacak K; Kidd M; Meuter L; Modlin IM
Endocr Relat Cancer; 2021 Oct; 28(11):731-744. PubMed ID: 34515661
[TBL] [Abstract][Full Text] [Related]
36. Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.
Yim SY; Moncayo VM; Pasquel FJ; Halkar RK
Clin Nucl Med; 2017 Dec; 42(12):964-965. PubMed ID: 28902732
[TBL] [Abstract][Full Text] [Related]
37. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic approach of pheochromocytomas and paragangliomas].
Gómez RM; Hernaiz M; de Miguel V; Aparicio LS; Marín MJ; Lupi S; Barontini M;
Hipertens Riesgo Vasc; 2019; 36(1):34-43. PubMed ID: 30078655
[TBL] [Abstract][Full Text] [Related]
39. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
40. Supportive Management of Patients with Advanced Pheochromocytomas and Paragangliomas Receiving PRRT.
Tsang ES; Funk G; Leung J; Kalish G; Kennecke HF
Curr Oncol; 2021 Jul; 28(4):2823-2829. PubMed ID: 34436013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]